Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade 3a Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02532257
What this trial is testing

Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma

Who this might be right for
Ann Arbor Stage II Follicular LymphomaAnn Arbor Stage II Marginal Zone LymphomaAnn Arbor Stage III Follicular Lymphoma+7 more
M.D. Anderson Cancer Center 48
Not applicableLooking for participantsNCT05377307
What this trial is testing

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

Who this might be right for
Diffuse Large B Cell LymphomaLarge B-cell LymphomaPrimary Mediastinal Large B Cell Lymphoma+2 more
Pell Bio-Med Technology Co., Ltd. 49
Testing effectiveness (Phase 2)Study completedNCT00670358
What this trial is testing

Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma

Who this might be right for
Lymphoma
Mayo Clinic 138
Testing effectiveness (Phase 2)Active Not RecruitingNCT03269669
What this trial is testing

Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

Who this might be right for
Grade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular Lymphoma+2 more
National Cancer Institute (NCI) 73
Large-scale testing (Phase 3)Looking for participantsNCT05045664
What this trial is testing

Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody

Who this might be right for
Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a
Heidelberg University 100
Large-scale testing (Phase 3)Study completedNCT02406092
What this trial is testing

Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A

Who this might be right for
Non-Hodgkin Lymphoma
Hoffmann-La Roche 139
Testing effectiveness (Phase 2)Looking for participantsNCT06442475
What this trial is testing

Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma

Who this might be right for
Ann Arbor Stage II Follicular LymphomaAnn Arbor Stage II Marginal Zone LymphomaAnn Arbor Stage III Follicular Lymphoma+6 more
University of Washington 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02446457
What this trial is testing

Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma+1 more
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT01849263
What this trial is testing

Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Grade 3a Follicular LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma+2 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Looking for participantsNCT06453044
What this trial is testing

Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma

Who this might be right for
Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3a Follicular Lymphoma+3 more
City of Hope Medical Center 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT04404088
What this trial is testing

Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma

Who this might be right for
Ann Arbor Stage III Grade 1 Follicular LymphomaAnn Arbor Stage III Grade 2 Follicular LymphomaAnn Arbor Stage III Grade 3 Follicular Lymphoma+4 more
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT04205409
What this trial is testing

Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+15 more
University of Washington 20
Not applicableActive Not RecruitingNCT06742879
What this trial is testing

A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients With Grade 3A High-risk Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Zhengzhou University 37
Testing effectiveness (Phase 2)Study completedNCT03015896
What this trial is testing

Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Grade 3a Follicular LymphomaRecurrent Burkitt LymphomaRecurrent Diffuse Large B-Cell Lymphoma+12 more
David Bond, MD 36
Testing effectiveness (Phase 2)Ended earlyNCT02008006
What this trial is testing

BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)

Who this might be right for
Follicular Lymphoma
Centre Leon Berard 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04450173
What this trial is testing

Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma

Who this might be right for
Ann Arbor Stage II Follicular LymphomaAnn Arbor Stage III Follicular LymphomaAnn Arbor Stage IV Follicular Lymphoma+3 more
University of California, Davis 40
Testing effectiveness (Phase 2)UnknownNCT03715309
What this trial is testing

R2 in the Treatment of Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Ruijin Hospital 115
Very early researchEnded earlyNCT02966730
What this trial is testing

Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy

Who this might be right for
Follicular LymphomaFollicular Lymphoma, Grade 1Follicular Lymphoma, Grade 2+1 more
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Looking for participantsNCT04883437
What this trial is testing

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

Who this might be right for
Grade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular Lymphoma+5 more
Emory University 49
Testing effectiveness (Phase 2)Study completedNCT02710643
What this trial is testing

"MIRO" Molecularly Oriented Immuno-radio-therapy

Who this might be right for
Follicular Lymphoma, Grade 1Follicular Lymphoma, Grade 2Follicular Lymphoma Grade 3A
Fondazione Italiana Linfomi - ETS 110
Next Page